RHRichard John Harvey

Richard John Harvey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

Recognitions

Top Cited Scholar (2026)

Richard John Harvey has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:

  • Raymond Sacks

    Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, NSW, Australia

    67 shared publications
  • Rodney J. Schlosser

    Division of Rhinology and Sinus Surgery, Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, SC

    33 shared publications
  • Larry Kalish

    Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research University of New South Wales Sydney Australia

    29 shared publications
  • Raquel Alvarado

    Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research University of New South Wales Sydney Australia

    27 shared publications
  • Janet Rimmer

    Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research University of New South Wales Sydney Australia

    19 shared publications
  • Peter Earls

    School of Clinical Medicine St Vincent's Healthcare Clinical Campus Faculty of Medicine and Health University of New South Wales Sydney Australia

    19 shared publications

Latest Publications

  • Open Access

    In vitro anti-inflammatory, antiviral, and antimicrobial activities of a multi-herbal menthol lozenge for upper respiratory tract infections

    by Supawadee Umthong, Nonthaneth Nalinratana, Wongsakorn Phongsopitanun, Richard J. Harvey, Autthaporn Salaiwarakul

  • Open Access

    Free Mucosal Grafting Is a Simple Adjunct for Rapid Re‐Epithelization in Septal Perforation Repair

    by Nicholas J. Campion, Ana Miguel Couto, Elizabeth Hua, Justin Qiao, Hardip Singh Gendeh, Andrés Rosenbaum Fuentes, Rhea Darbari Kaul, Raquel Alvarado, Christine Choy, Amal Elhage, et al.

    Objective: Mucosal grafting has become more established in rhinology. While it is accepted that free mucosal grafts take to bone and vascularized recipient beds, the use of mucosal grafting on the contralateral side during nasal septal perforation (NSP) repair with vascularized flaps is not well recognized, but is an important adjunct to ensure healthy reepithelialization of the contralateral septum. Methods: Consecutive patients undergoing endoscopic NSP repair with a contralateral free mucosal graft between 2014 and 2025 were included. Grafts were placed opposite the flap on a collagen matrix interlay. The primary outcome was the integration of the free graft judged as complete, partial, or failed. Secondary outcomes included the overall anatomical closure, Miglani endoscopic score, and nasal symptoms assessed via the SNOT‐22 nasal subdomain. Results: Ninety patients (age 44.3 ± 15.5 years; 56.7% male) were followed up for a median of 4.0 [2.0–7.0] months. Most repairs utilized an anterior ethmoidal artery flap (95.6%). Free graft integration was complete in 85.6% of all cases (6.7% partial). Anatomical closure was achieved in 90.0% and free graft integration was complete in 92.6% of those patients. Preoperative vs. postoperative endoscopic assessment (3.0 [2.0–5.0] vs. 0.0 [0.0–1.0], p < 0.001) and nasal subdomain scores improved significantly (9.0 [6.0–14.0] vs. 4.0 [2.0–10.0], p < 0.001). Conclusion: Contralateral free mucosal grafts heal reliably in endoscopic NSP repair, with complete healing in over 93% of patients with successful closure. The technique is simple to perform and assists in achieving rapid reepithelialization in an area at high risk of desiccation and poor healing. Level of Evidence: 4.

  • Open Access

    Craniofacial Resection for Advanced Cutaneous Squamous Cell Carcinoma: Results From the 2nd International Collaborative Case‐Series

    by Michael J. C. Schachtel, Benedict J. Panizza, James J. Bowman, Catherine Barnett, Cristina Valero, Ian Ganly, Snehal G. Patel, Helena Levyn, Dauren Adilbay, Alana Eagan, et al.

    Background: Robust outcome data for anterior skull base cutaneous squamous cell carcinoma (cSCC) are limited, particularly as emerging therapies reshape management. We evaluated survival and prognostic factors following craniofacial resection. Methods: Retrospective multi‐institutional case‐series (1995–2015) of patients who underwent skull base surgery for anterior face/scalp cSCC. Kaplan–Meier and Cox regression analyses assessed disease‐free (DFS), disease‐specific (DSS), and overall survival (OS). Results: Among 112 patients, most had T4 (86.6%) and recurrent (71.4%) disease. Clear margins were achieved in 32.1%; 40.2% were involved. Five‐year DFS, DSS, and OS were 46.9%, 68.4%, and 52.3%, respectively. Intracranial extension independently predicted worse OS (HR:6.54 [95% CI:2.61,16.38]) and DSS (HR:12.39 [95% CI:2.72,56.45]). Involved margins predicted recurrence on univariable analysis. Adjuvant therapy, predominantly post‐operative radiotherapy, improved OS (HR: 0.54 [95% CI: 0.30,0.97]). Complications occurred in 38.4%, with 4.5% perioperative mortality. Conclusion: Advanced anterior skull base cSCC carries substantial morbidity and modest survival. These data provide a benchmark against which immunotherapy‐based strategies should be evaluated.

  • Open Access

    Superior Labial Artery Flap for Septal Perforation Repair: The Boxer's Flap

    by Nicholas J. Campion, Zhanna Mokoyan, Viktoriya Stepanova, Isam Alobid, Richard J. Harvey, Yury Rusetsky

    Objectives: Anterior nasal septal perforations (NSPs) can cause significant morbidity and are often challenging to repair in revision settings where posterior septal mucosa lack integrity, are difficult to raise, or are traumatized. We describe an anteriorly pedicled nasal floor mucoperiosteal flap based on the superior labial artery (SLA) and report anatomical and symptomatic outcomes in patients where traditional anterior ethmoid and greater palatine artery flaps are not readily available. Methods: A case series of consecutive adult patients undergoing endoscopic NSP repair using an SLA‐based anterior pedicled floor flap was performed. Outcomes included anatomical closure, Miglani endoscopic score, symptom evaluation with SNOT‐22 and nasal subdomain scores. The definition of outcome was defined by both resolution of clinical symptoms and anatomical closure, with “complete” being both. Results: Twenty‐one patients (age 41.5 ± 10.9 years; 57.1% female) were followed for 9.4 ± 3.6 months. Most perforations were anterior (85.7%) and iatrogenic (surgical trauma) in etiology, with a mean area of 92.6 ± 71.9 mm 2 . Anatomical closure was achieved in 90.5 [71.1–97.3]% of cases, with partial closure in 9.5 [2.7–28.9]%. Endoscopy assessment improved (Miglani 3.14 ± 1.56 v 0.62 ± 0.86; p < 0.001). Symptoms improved in both nasal subdomain (14.1 ± 6.2 v 3.5 ± 3.2, p < 0.001) and SNOT‐22 (38.6 ± 21.8 v 9.8 ± 11.5, p < 0.001). Complete success (anatomical closure with symptom resolution) was achieved in 90.5 [71.1–97.3]%. Conclusions: The SLA‐based nasal floor flap provides high closure rates and symptomatic improvement in NSP cases where traditional septal flaps are not feasible. Level of Evidence: 4.

  • Open Access

    Correlation of Patient-Reported Symptoms With Rhinogram Features Beyond Simple Airway Resistance

    by Rhea Darbari Kaul, Raquel Alvarado, Christine Choy, Haiyang Sun, Sidong Liu, Elizabeth Hua, Liam Grouse, Masoud Haghighi, Kate Liang, Emma Zou, et al.

    Introduction: Rhinomanometry, a reference measure for the nasal airway, is often considered a research tool with only weak-to-moderate correlations with patient symptoms. However, like lung spirometry curves offer information beyond forced expiratory volume (FEV), rhinomanometry curves (rhinograms) have characteristics beyond simple nasal resistance at 150 Pascals. This study explored the correlation between rhinogram curve features and patient-reported outcomes (PROMs), when compared with nasal airway resistance. Methods: A diagnostic cross-sectional study was conducted on patients from a rhinology clinic. PROMs collected included ordinal nasal obstruction and visual analogue scale (VAS) of the more obstructed side. Rhinomanometry curves underwent mathematical polynomial fitting to extract 835 features. The primary outcome was correlation using Spearman’s rho (ρ) comparing curve-derived features with nasal airway resistance at 150 Pascals. Machine learning was applied to the top 8 correlated features to generate an AI predictive model. Results: About 601 patients (mean age 45 ± 16 years, 45% female) were analysed. Curve-derived features (ρ = 0.305) correlated more than total NAR at 150 Pa (ρ = 0.222) with VAS. Similarly with ordinal nasal obstruction, curve-derived features correlated more (ρ = 0.230) than total NAR at 150 Pa (ρ = 0.112). The best performing AI prediction models achieved correlations of 0.133 (VAS) and 0.117 (nasal obstruction). Conclusion: This study offers a novel method for rhinogram analysis with curve-derived features for correlation and predictive modelling. Whilst correlation scores remain weak-moderate with PROMs, they outperform nasal airway resistance. Therefore, rhinograms produced from rhinomanometry may offer more clinical information than a simplistic numerical resistance testing.

  • Open Access

    Extent of Sinus Surgery Is Associated With Disease Control in Biologic Treated Type 2 Dominant CRS

    by Nicholas J. Campion, Peta‐Lee Sacks, Lu Hui Png, Ruoxin Hua, Rhea Darbari Kaul, Raquel Alvarado, Christine Choy, Raymond Sacks, Peter Earls, Raewyn G. Campbell, et al.

    Background: A greater benefit of biologics is observed after surgery in Type 2 chronic rhinosinusitis with nasal polyps (CRSwNP). However, the extent of surgery remains undefined in many studies. This study evaluated the extent of surgery on disease control in patients receiving biologics for refractory Type 2 dominant CRSwNP. Methods: A cross‐sectional study was performed on patients with CRSwNP treated with biologics for ≥ 6 months at a tertiary center. All patients had undergone prior sinus surgery, which included a sphenoethmoidectomy and then extension via Draf I, IIa, IIb, IIc, or III. Disease control was defined as having a SNOT‐22 ≤ 30, endoscopic modified Lund–Mackay ≤ 4, and the absence of rescue therapy within 6 months. Comparisons were made across surgical and biologic groups, and logistic regression was used to identify factors associated with disease control. Results: A total of 159 patients were assessed (age 50.9 ± 12.8 years, 45.3% female). Disease control was achieved in 49.1% of patients. Disease control was greater with extended surgery (Draf III 60.8% [49.7%–70.8%] vs. Draf IIc 68.3% [53.0%–80.4%] vs. Draf IIa 8.7% [2.4%–26.8%] vs. Draf I 0% [0.0%–19.4%]; p < 0.001). The control was similar across biologic types (anti‐IL‐4αR 63.3% [45.5%–78.1%] vs. anti‐IL‐5/5R 45.7% [37.3%–54.3%]; p = 0.083). On regression, extended surgery (Draf III + IIc) was associated with disease control (Draf III/IIc vs. Draf IIa/I OR: 110.2 [12.7–14,682.5]) but not biologic type (anti‐IL‐4αR vs. anti‐IL‐5/5R OR: 2.2 [0.7–7.2]). However, class switching had already occurred in 15.1% of patients initially treated with anti‐IL‐5/5R. Conclusions: Disease control was greatest in CRSwNP patients who had both extended sinus surgery and optimized biologic treatment.